INS and metabolic disease: In this study, we aimed to develop an IR model by exogenous insulin administration that permits us to show the stages of hyperinsulinemia, loss of insulin sensibility, and early IR with their respective changes at the hepatic level of redox imbalance, inflammation, impairment of insulin signaling, and metabolic disorders.